The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | N | Nervous system | |
| 2 | N01 | Anesthetics | |
| 3 | N01B | Anesthetics, local | |
| 4 | N01BB | Amides | |
| 5 | N01BB02 | Lidocaine |
| Active Ingredient | Description | |
|---|---|---|
| Lidocaine |
Lidocaine, like other local anaesthetics, causes a reversible blockade of impulse propagation along nerve fibres by preventing the inward movement of sodium ions through the nerve membrane. Local anaesthetics of the amide-type are thought to act within the sodium channels of the nerve membrane. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| CATHEJELL Jelly in collapsible syringe | Health Products and Food Branch (CA) | MPI, CA: SPM | |
| LIDBREE Intrauterine gel | Health Products Regulatory Authority (IE) | MPI, EU: SmPC | |
| XYLOCAINE Spray | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| ZINGO Powder intradermal injection | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
